Novartis Reports Positive Data from COVID-19 Antiviral Drug Trial Novartis will license a new drug it has been developing with Molecular Partners to treat COVID-19 after getting positive trial data, the companies ...
Novartis Embarks on 10-Year Pledge to Create Solutions for Health Equity East Hanover-based Novartis and the Novartis US Foundation this week announced a planned 10-year collaboration with Coursera, the National Medical ...
